…
comment: The repository administrator has not yet configured an RDF license.
primary topic: CLINICAL PHARMACOLOGY OF HYPOGLYCEMIC DRUGS

CLINICAL PHARMACOLOGY OF HYPOGLYCEMIC DRUGS
type: AcademicArticle
type: Article
abstract: In patients with diabetes mellitus type 2, non-insulin antihyperglycemic therapy is aimed to control symptoms of hyperglycemia and to limit microvascular complications. It is introduced early after diagnosis of the disease. Antihyperglycemic agents may predominantly act through one of four ways. The involved mechanisms are: enhancement of insulin secretion, through which act sulfonylureas, meglitinides and two types of incretin mimetics - glucagon-like peptide-1 (GLP-1) receptor agonists and inhibitors of dipeptidyl peptidase-4 (DPP-4) activity -gliptins; suppression of hepatic glucose production - biguanides; enhanced sensitivity to insulin - thiazolidinediones, and decrease of the rate or extent of glucose absorption: islet amyloid polypeptide (amylin) analogs and α-glucosidase inhibitors. With exception of GLP-1 receptor agonists and pramlintide, a synthetic form of amylin, all these drugs are administered orally.
date: 2024-01-20
status: published
author list: authors
type: EPrint
type: ArticleEPrint
is part of: repository

Center for Tech and Media Research
type: Organization

Multidisciplinary Journal of Science and Technology
type: Collection

Abduraxmonov Alijon Shodmon o'g'li
type: Person
given name: Abduraxmonov Alijon Shodmon
family name: o'g'li

Rayimnazarov Shaxzot Muhiddin o'g'li
type: Person
given name: Rayimnazarov Shaxzot Muhiddin
family name: o'g'li

Chariev Muzaffar Yuldashevich
type: Person
given name: Chariev Muzaffar
family name: Yuldashevich

HTML Summary of #52936 CLINICAL PHARMACOLOGY OF HYPOGLYCEMIC DRUGS
format: text/html
primary topic: CLINICAL PHARMACOLOGY OF HYPOGLYCEMIC DRUGS